324
Participants
Start Date
August 15, 2024
Primary Completion Date
December 15, 2028
Study Completion Date
December 15, 2028
Dexrazoxane
Day 1 Cycle 1-6: Dexrazoxane 500 mg/m2 (iv) will be given 30 minutes before doxorubicin infusion and should be infused during 15 minutes.
Rituximab
Day 1 Cycle 1-6: 375 mg/m2 (iv)
Cyclophosphamide
Day 1 Cycle 1-6: 750 mg/m2 (iv)
Doxorubicin
Day 1 Cycle 1-6: 50 mg/m2 (iv)
Vincristine
Day 1 Cycle 1-6: 1.4 mg/m2 (max 2 mg) (iv)
Prednisolone
Day 1-5 Cycle 1-6: 100 mg (oral)
Lenalidomide
Day 1-14 Cycle 1-6: 15 mg day (oral) Only in case of a double hit lymphoma.
Pegfilgrastim
6 mg (1 dose per cycle) in case of neutropenia. Pegfilgastim is mandatory in patients that receive R2-CHOP21.
RECRUITING
NL-Den Bosch-JBZ, 's-Hertogenbosch
NOT_YET_RECRUITING
NL-Almelo-ZGTALMELO, Almelo
NOT_YET_RECRUITING
NL-Amstelveen-AMSTELLAND, Amstelveen
NOT_YET_RECRUITING
NL-Apeldoorn-GELREAPELDOORN, Apeldoorn
NOT_YET_RECRUITING
NL-Arnhem-RIJNSTATE, Arnhem
NOT_YET_RECRUITING
NL-Breda-AMPHIA, Breda
NOT_YET_RECRUITING
NL-Delft-RDGG, Delft
NOT_YET_RECRUITING
NL-Dordrecht-ASZ, Dordrecht
NOT_YET_RECRUITING
NL-Eindhoven-CATHARINA, Eindhoven
NOT_YET_RECRUITING
NL-Eindhoven-MAXIMAMC, Eindhoven
NOT_YET_RECRUITING
NL-Goes-ADRZ, Goes
NOT_YET_RECRUITING
NL-Groningen-MARTINI, Groningen
NOT_YET_RECRUITING
NL-Harderwijk-STJANSDALHARDERWIJK, Harderwijk
NOT_YET_RECRUITING
NL-Hilversum-TERGOOI, Hilversum
NOT_YET_RECRUITING
NL-Hoofddorp-SPAARNEGASTHUIS, Hoofddorp
NOT_YET_RECRUITING
NL-Nieuwegein-ANTONIUS, Nieuwegein
NOT_YET_RECRUITING
NL-Nijmegen-CWZ, Nijmegen
NOT_YET_RECRUITING
NL-Rotterdam-IKAZIA, Rotterdam
NOT_YET_RECRUITING
NL-Schiedam-FRANCISCUSVLIETLAND, Schiedam
NOT_YET_RECRUITING
NL-Sittard-ZUYDERLAND MC, Sittard
NOT_YET_RECRUITING
NL-Sneek-ANTONIUSSNEEK, Sneek
NOT_YET_RECRUITING
NL-Den Haag-HAGA, The Hague
RECRUITING
NL-Utrecht-UMCUTRECHT, Utrecht
NOT_YET_RECRUITING
NL-Venlo-VIECURI, Venlo
NOT_YET_RECRUITING
NL-Zwolle-ISALA, Zwolle
UMC Utrecht
OTHER
Amsterdam University Medical Centers
UNKNOWN
The Dutch Network for Cardiovascular Research (WCN)
UNKNOWN
Stichting Hemato-Oncologie voor Volwassenen Nederland
OTHER